Status | Study |
Completed |
Study Name: Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder Condition: Obsessive Compulsive Disorder Date: 2010-04-09 Interventions: Drug: Agomelatine A |
Completed |
Study Name: Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder Condition: Obsessive Compulsive Disorder Date: 2009-04-14 Interventions: Behavioral: Cognitive-behavioral therapy |
Completed |
Study Name: Study of Memantine Augmentation in Severe Obsessive-Compulsive Disorder Condition: Obsessive-Compulsive Disorder Date: 2009-03-25 |
Completed |
Study Name: D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder Condition: Obsessive-compulsive Disorder Date: 2009-03-17 Interventions: Behavioral: Cognitive-behavioral therapy |
Completed |
Study Name: Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD) Condition: Obsessive Compulsive Disorder Date: 2008-11-20 Interventions: Drug: ondansetron ondansetron hydrochloride (oral solution) dosage of 0.25 mg twice a day for 6 weeks fo |
Completed |
Study Name: Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder Condition: Obsessive-Compulsive Disorder Date: 2008-02-29 Interventions: Drug: Paliperidone Paliperidon |
Terminated |
Study Name: Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD) Condition: Obsessive Compulsive Disorder Date: 2007-08-10 Interventions: Drug: Minocycline Capsules |
Completed |
Study Name: Efficacy of Treatment for Obsessive Compulsive Disorder Condition: Obsessive Compulsive Disorder Date: 2007-04-03 |
Completed |
Study Name: Adjunctive Glycine for Obsessive Compulsive Disorder Condition: Obsessive Compulsive Disorder Date: 2006-11-28 Interventions: Drug: glycine Other: placebo |
Completed |
Study Name: Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study Condition: Obsessive Compulsive Disorder Date: 2006-04-25 Interventions: Drug: Quetiapine |